Day:

Greater efforts are needed to invest in infrastructure, foster inclusive study designs and align research agendas.

ICH opens consultation on draft E22 guidance for patient preference studies

A draft ICH E22 guideline on patient preference studies is now open for public comment via the European Medicines Agency until 12 April 2026.